We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UPS Expands in Healthcare Logistics With $48 Million Investment
Read MoreHide Full Article
Key Takeaways
UPS is investing $48M in 27 temperature-controlled cross-dock facilities across global markets.
The facilities support short-term storage between air and ground while maintaining strict temperature ranges.
UPS aims to move time- and temperature-sensitive healthcare shipments across air, ocean, ground.
United Parcel Service, Inc. (UPS - Free Report) is strengthening its competitive position in the healthcare logistics industry through its latest $48 million investment in 27 temperature-controlled freight cross-dock facilities globally. These facilities are streamlined for speed and short-term storage between air and ground movements, alongside maintaining specific temperature requirements. These facilities are located in key U.S. and international markets, including Europe, Asia and the Americas.
This latest investment announcement solidifies UPS’ global cold-chain network as demand rises for medicines requiring strict temperature ranges of 2 to 8 degrees Celsius, 15 to 25 degrees Celsius and frozen.
Kate Gutmann, executive vice president and president of International, Healthcare and Supply Chain Solutions at United Parcel Service, stated, “We have aligned our investments with our Healthcare customers’ specialized needs. Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world. This effort – and all of our work in healthcare logistics – extends from a deep understanding that we’re doing more than moving packages. We are helping patients access the medications and treatments they need.”
To Conclude
With therapies like cell and gene treatments, mRNA platforms and GLP-1 injectables evolving, healthcare supply chains are becoming more sensitive, and temperature regulations are a key element of the system. The thriving biologics pipeline is making the cold-chain logistics more complex.
Given that the industry demand for temperature-sensitive biologics is anticipated to increase, the latest investment decision by UPS seems to be a strategic business move on its part.
This is not the first time UPS has widened its network in healthcare logistics through acquisitions. To name a few, these include the acquisitions of Bomi Group in 2022, Frigo Trans and BPL in Europe and Andlauer Healthcare Group in North America in 2025. These were followed by the recent expansion of UPS’s Incheon, Korea air hub in 2026 to help the expanding pharmaceutical trade flows.
John Bolla, president of UPS Healthcare, stated, “Biologics and personalized treatments are driving better, more targeted care for patients. These investments reflect our commitment to continue to align our leading end-to-end supply chain to protect innovative treatments and diagnostics, supporting better patient outcomes.”
The aim is to maintain a supply chain which provides both time- and temperature-sensitive healthcare shipments smoothly across air, ocean, ground and final mile.
UPS’ Zacks Rank & Stocks to Consider
United Parcel Service currently carries a Zacks Rank #3 (Hold).
Investors interested in the Zacks Transportation sector may consider Expeditors International of Washington, Inc. (EXPD - Free Report) and Teekay Tankers Ltd (TNK - Free Report) .
Expeditors has an expected earnings growth rate of 11.9% for 2026. The company has an encouraging earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 13.96%.
Teekay Tankers Ltd currently sports a Zacks Rank #1.
TNK has an expected earnings growth rate of 98% for the current year. The company has an encouraging earnings surprise history. Its earnings topped the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 10.2%.
View the Zacks #1 Rank List
Image: Bigstock
UPS Expands in Healthcare Logistics With $48 Million Investment
Key Takeaways
United Parcel Service, Inc. (UPS - Free Report) is strengthening its competitive position in the healthcare logistics industry through its latest $48 million investment in 27 temperature-controlled freight cross-dock facilities globally. These facilities are streamlined for speed and short-term storage between air and ground movements, alongside maintaining specific temperature requirements. These facilities are located in key U.S. and international markets, including Europe, Asia and the Americas.
This latest investment announcement solidifies UPS’ global cold-chain network as demand rises for medicines requiring strict temperature ranges of 2 to 8 degrees Celsius, 15 to 25 degrees Celsius and frozen.
Kate Gutmann, executive vice president and president of International, Healthcare and Supply Chain Solutions at United Parcel Service, stated, “We have aligned our investments with our Healthcare customers’ specialized needs. Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world. This effort – and all of our work in healthcare logistics – extends from a deep understanding that we’re doing more than moving packages. We are helping patients access the medications and treatments they need.”
To Conclude
With therapies like cell and gene treatments, mRNA platforms and GLP-1 injectables evolving, healthcare supply chains are becoming more sensitive, and temperature regulations are a key element of the system. The thriving biologics pipeline is making the cold-chain logistics more complex.
Given that the industry demand for temperature-sensitive biologics is anticipated to increase, the latest investment decision by UPS seems to be a strategic business move on its part.
This is not the first time UPS has widened its network in healthcare logistics through acquisitions. To name a few, these include the acquisitions of Bomi Group in 2022, Frigo Trans and BPL in Europe and Andlauer Healthcare Group in North America in 2025. These were followed by the recent expansion of UPS’s Incheon, Korea air hub in 2026 to help the expanding pharmaceutical trade flows.
John Bolla, president of UPS Healthcare, stated, “Biologics and personalized treatments are driving better, more targeted care for patients. These investments reflect our commitment to continue to align our leading end-to-end supply chain to protect innovative treatments and diagnostics, supporting better patient outcomes.”
The aim is to maintain a supply chain which provides both time- and temperature-sensitive healthcare shipments smoothly across air, ocean, ground and final mile.
UPS’ Zacks Rank & Stocks to Consider
United Parcel Service currently carries a Zacks Rank #3 (Hold).
Investors interested in the Zacks Transportation sector may consider Expeditors International of Washington, Inc. (EXPD - Free Report) and Teekay Tankers Ltd (TNK - Free Report) .
EXPD currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Expeditors has an expected earnings growth rate of 11.9% for 2026. The company has an encouraging earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 13.96%.
Teekay Tankers Ltd currently sports a Zacks Rank #1.
TNK has an expected earnings growth rate of 98% for the current year. The company has an encouraging earnings surprise history. Its earnings topped the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average beat of 10.2%.